Ameriprise
PMVP icon

Ameriprise’s PMV Pharmaceuticals PMVP Stock Holding History

Ameriprise’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,237
Closed -$16.4K – 4221
2026
Q1 		$16.4K Sell
13,237
-51,877
-80% -$66K ﹤0.01% 4032
2025
Q4 		$81.4K Buy
65,114
+54,174
+495% +$72.6K ﹤0.01% 4017
2025
Q3 		$15.3K Buy
+10,940
New +$15.1K ﹤0.01% 4044
2025
Q2 		– Sell
-18,007
Closed -$19.6K – 4092
2025
Q1 		$19.6K Sell
18,007
-4,800
-21% -$6.52K ﹤0.01% 3985
2024
Q4 		$34.4K Sell
22,807
-16,715
-42% -$26.5K ﹤0.01% 4030
2024
Q3 		$58.9K Sell
39,522
-10,272
-21% -$15.9K ﹤0.01% 3872
2024
Q2 		$80.7K Hold
49,794
– – ﹤0.01% 3790
2024
Q1 		$84.7K Sell
49,794
-75,586
-60% -$141K ﹤0.01% 3788
2023
Q4 		$389K Buy
125,380
+43,195
+53% +$114K ﹤0.01% 3540
2023
Q3 		$505K Buy
82,185
+865
+1% +$5.95K ﹤0.01% 3412
2023
Q2 		$509K Sell
81,320
-285
-0.3% -$1.49K ﹤0.01% 3430
2023
Q1 		$389K Buy
81,605
+1,280
+2% +$9.01K ﹤0.01% 3519
2022
Q4 		$699K Sell
80,325
-5
-0% -$53 ﹤0.01% 3277
2022
Q3 		$956K Sell
80,330
-1,521
-2% -$22K ﹤0.01% 3133
2022
Q2 		$1.17M Buy
81,851
+22,258
+37% +$324K ﹤0.01% 3053
2022
Q1 		$1.24M Buy
59,593
+8,006
+16% +$141K ﹤0.01% 3118
2021
Q4 		$1.19M Buy
51,587
+19,371
+60% +$468K ﹤0.01% 3182
2021
Q3 		$960K Sell
32,216
-2,990
-8% -$95.5K ﹤0.01% 3181
2021
Q2 		$1.14M Buy
35,206
+17,887
+103% +$597K ﹤0.01% 3169
2021
Q1 		$570K Buy
17,319
+13,706
+379% +$540K ﹤0.01% 3348
2020
Q4 		$222K Buy
+3,613
New +$142K ﹤0.01% 3601

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Ameriprise's PMVP Position: Q2 2026 in Review

Ameriprise sold out of PMV Pharmaceuticals (PMVP) in Q2 2026, closing a stake of 13,237 shares — an estimated $16.4K sold.

Ameriprise first reported a position in PMVP in Q4 2020 and held it in 21 quarters. The position peaked at $1.24M in Q1 2022. 64 funds tracked by Wall St. Rank hold PMVP as of Q2 2026.

  • Ameriprise reported no remaining PMV Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Ameriprise sold 13,237 PMV Pharmaceuticals shares in Q2 2026, an estimated $16.4K.
  • Ameriprise first reported a position in PMV Pharmaceuticals in Q4 2020 and held it in 21 quarters.
  • Ameriprise's PMV Pharmaceuticals position peaked at $1.24M in Q1 2022.
  • 64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.